From the discovery of stem cells to implementing cell therapies in the clinic, Toronto is a global leader in progressing regenerative medicine and cell based therapies to the bedside.
Powered by big data and next generation sequencing, Toronto innovators are leading the world in developing personalized therapies for cancer and rare diseases.
The place which the “Godfather of AI” calls home, Toronto powers the healthcare system with cutting edge Artificial Intelligence technology, applications and talent.
Our clinician entrepreneurs develop novel life-saving devices and tests them in real world environments to be international leaders in medical devices and software development.
Toronto Region is the fastest growing tech cluster in North America, outpacing Silicon Valley and Boston.
MaRS Discovery District is the largest urban innovation hub; located in the heart of Toronto.
Johnson & Johnson built JLABS in Toronto to take advantage of the innovation ecosystem.
The Centre for Commercialization of Regenerative Medicine are scaling regenerative medicine discoveries into clinical application. CCRM is a not-for-profit organization that supports the development and commercialization of cell and gene therapies, and regenerative medicine technologies. CCRM’s newly built 40, 000 sq ft Centre for Advanced Therapeutic Cell Technologies facility is a great example of public-private partnerships, leveraging $40M from GE Healthcare, and FedDev Ontario in agreement to solve cell therapy manufacturing challenges.
Structural Genomics Consortium Led out of Toronto, and engaging an ever-broadening number of public and private sector partners. To date, eight pharmaceutical companies are collaborating in and co-financing SGC activities. Outcomes to date include more than 25 ongoing clinical trials and the creation of many start-up companies.
Klick Health’s data scientists recently developed algorithms to predict blood glucose levels for patients with Type 1 diabetes. Klick presented this research at the Knowledge Discovery in Healthcare workshop at the 2018 International Joint Conference on Artificial Intelligence in Stockholm.
With its diverse team of data scientists, biomedical engineers, social scientists, and its proven commercial, scientific, medical and technological expertise, Klick is distinguishing itself on the world stage. Its ongoing, focussed investment in research and AI solutions are working to help improve the well-being of patient populations.
Just four years old, Synaptive Medical is a young company making huge strides in the field of neurosurgery by providing technologically advanced solutions to neurosurgeons.
Privately funded and home-grown in Toronto, Synaptive has recruited a talented and dedicated team of scientists and engineers, with expertise in optics, robotics and image-guided navigation, to work collaboratively on the development of neurosurgical solutions to key medical problems.